Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ureter Neoplasms”

184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 184 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00006026
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 21
Testing effectiveness (Phase 2)Looking for participantsNCT07087860
What this trial is testing

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more
Mayo Clinic 70
Early research (Phase 1)Ended earlyNCT06630247
What this trial is testing

A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more
Exelixis 9
Testing effectiveness (Phase 2)Looking for participantsNCT05775471
What this trial is testing

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
Jonsson Comprehensive Cancer Center 21
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Testing effectiveness (Phase 2)Study completedNCT04602078
What this trial is testing

Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
Spanish Oncology Genito-Urinary Group 82
Testing effectiveness (Phase 2)Study completedNCT00002914
What this trial is testing

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 40
Large-scale testing (Phase 3)Looking for participantsNCT04628767
What this trial is testing

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
National Cancer Institute (NCI) 131
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Very early researchActive Not RecruitingNCT02812420
What this trial is testing

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

Who this might be right for
HydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more
M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT03013920
What this trial is testing

CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract CancerUrothelial CarcinomaUreter Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848519
What this trial is testing

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+11 more
Emory University 6
Testing effectiveness (Phase 2)Study completedNCT00077688
What this trial is testing

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Bladder NeoplasmsUreteral NeoplasmsUrethral Neoplasms+1 more
Achieve Life Sciences 44
Testing effectiveness (Phase 2)Study completedNCT00004203
What this trial is testing

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University of Chicago 20
Testing effectiveness (Phase 2)UnknownNCT00005958
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT00363883
What this trial is testing

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Who this might be right for
Localized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+2 more
National Cancer Institute (NCI) 14
Not applicableLooking for participantsNCT06120387
What this trial is testing

Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer

Who this might be right for
Locally AdvancedUrothelial Carcinoma Ureter
Xuesong Li 90
Not applicableLooking for participantsNCT06652022
What this trial is testing

Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs

Who this might be right for
Oligometastatic DiseaseUreter CancerRenal Pelvic Carcinoma
Peking University First Hospital 102
Next Page